Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

1 result loaded, newest first. End of these results.

News 2026-06-26 11:00 UTC

AXSM Initiates ADHD Trial

Axsome Therapeutics initiates FOCUS-3 Phase 3 trial of Solriamfetol in adolescents with Attention Deficit Hyperactivity Disorder (ADHD)